	Front-line chemo-immunotherapy for advanced penile cancer: ready for prime time? Br J Cancer Thomas Z, Pettaway CA, Alhalabi O, Campbell MT, Johns AC. PMID: 42337045 [PubMed - as supplied by publisher]
	How will PLUDO, PSMAfore, SPLASH, and ECLIPSE Impact Prostate Cancer Management? Eur Urol Focus Beauregard JM, Ong M, Pouliot F. PMID: 42336749 [PubMed - as supplied by publisher]
	Re: Multicenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men with Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE). Eur Urol Ma H, Zhang L. PMID: 42336727 [PubMed - as supplied by publisher]
	MRI-targeted versus systematic needle core biopsies in prostate cancer: a patient-based analysis of potential diagnostic and biologic underestimation. J Clin Pathol Saeed F, Osunkoya AO. PMID: 42336636 [PubMed - as supplied by publisher]
	A Pilot Study of Ex-vivo High Frequency Ultrasound and Core Needle Biopsy to Improve Clinical Tumor Staging of Cancer of the Bladder. Urology Roberson DS, Wang MK, McLeay Ii MT, Wei N, Potretzke T, Gupta S, Cheville JC, Kern R, Lomas D, Mynderse L, Khanna A, Shah P, Tollefson MK, Jeffrey Karnes R, Boorjian SA, Sharma V. PMID: 42336158 [PubMed - as supplied by publisher]
	Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO study. Cell Rep Med Grande E, Sibai M, Grases D, Andrada E, Reig O, Escobosa M, Azueta A, Castellano D, Puente J, Martínez de Villarreal J, Font A, Alonso-Gordoa T, Benítez R, Moreno-Oya A, Álvarez-Maestro M, Burgos J, Climent MA, Domínguez M, Galván P, Galante I, García JF, Perez E, García Del Muro X, Guerrero-Ramos F, Marqués M, Maroto P, Paramio JM, Pinto A, Prat A, Malats N, Durán I, Porta-Pardo E, Real FX. PMID: 42335902 [PubMed - as supplied by publisher]
	A Harmonized International Database of More Than 10,000 Pediatric Renal Tumor Patients From 30 Years of SIOP-RTSG Studies. JCO Clin Cancer Inform Roy P, Schut I, Graf N, Verschuur A, Chowdhury T, Spreafico F, Brok J, Ramirez-Villar GL, de Camargo B, Godzinski J, Vujanic G, Melchior P, Koolma R, Al-Saadi R, Gessler M, Duncan C, Schenk JP, Furtwängler R, Bonnange HS, Metzger S, Baars D, Pritchard-Jones K, van den Heuvel-Eibrink MM, van Tinteren H. PMID: 42335412 [PubMed - indexed for MEDLINE]
	Years of Life Lost From Metastatic Prostate Cancer According to Treatment Era and Race/Ethnicity. Prostate Quarta L, Petix M, Filzmayer M, Orlandi F, Polverino F, Goyal JA, Ferro M, Chun FKH, Micali S, Longo N, Shariat SF, Barletta F, Stabile A, Gandaglia G, Montorsi F, Saad F, Briganti A, Karakiewicz PI. PMID: 42335306 [PubMed - as supplied by publisher]
	Contrast-Enhanced Ultrasound as a Next-Step Tool After Indeterminate CT in ESRD. Ultrasound Q Mc Caughey M, Gustainis D, Ambrosio M, Sambommatsu Y, Imai D, Sharma A, Khan A, Lee SD, Bruno D, Prasad U, Saeed M. PMID: 42335288 [PubMed - indexed for MEDLINE]
	Correlation of Prostate Tumor Laterality with Pelvic Lymph Node Metastasis Patterns- A Retrospective Observational Study. Urol Int Masoumi N, Alinejad Khorram A, Beheshti M, Rabani S, Torabi A, Razi A, Jafarlou D. PMID: 42334984 [PubMed - as supplied by publisher]
	Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study. Minerva Urol Nephrol Rescigno P, Taha T, Fita MJ, Matthews D, Fujita K, Lolli C, DI Costanzo F, Juárez A, Ürün Y, Yazgan SC, Li H, Facchini G, Quiroga MN, Sammarco E, Bögemann M, Santini D, Baranseh J, Roviello G, Kopp RM, Fiala O, Büttner T, Carrozza F, Ansari J, Tural D, Conteduca V, Molina-Cerrillo J, Alonso-Gordoa T, Bourlon MT, Palacios GA, Paolieri F, Zgura A, DI Rocco R, Lacerenza LG, Matrana MR, Martignetti A, Massari F, Soares A, Monteiro FS, Bastos DA, Gaughan L, Wenzel M, Mandel P, Banna GL, Santoni M. PMID: 42334408 [PubMed - as supplied by publisher]
	Clinically Significant Prostate Cancer in Patients Undergoing Holmium Laser Enucleation of Prostate for Benign Hyperplasia: A Preoperative Nomogram and a Postoperative Surveillance Protocol. J Endourol Singh G, Bakbak H, Abdelaziz A, Resnik S, Ospina JV, Katz JE, Marcovich R, Khandekar A, Punnen S, Gonzalgo ML, Parekh DJ, Shah HN. PMID: 42333981 [PubMed - as supplied by publisher]
	UBE2C contributes to malignant phenotypes in clear cell renal cell carcinoma via cell cycle and apoptosis regulation. PeerJ Qin T, Liang J, Ya W, Long Y, Wu J, Meng D, Gan F. PMID: 42333228 [PubMed - indexed for MEDLINE]
	Hugoâ„¢ RAS versus da Vinci(Â®) for robot-assisted radical prostatectomy in localized prostate cancer: a GRADE-assessed systematic review and meta-analysis of prospective comparative studies. BMC Surg Mirza W, Haider MH, Habib T, Ali RN, Moeen-Ud-Din MB, Hadhoud AM. PMID: 42332746 [PubMed - as supplied by publisher]
	Exploring the relationship between potential hepatotoxicity and novel hormonal therapies in prostate cancer: a systematic review and meta-analysis. BMC Cancer Ma L, Fan L, Luo X, Huang Z, Dai J, Wu Y, Zhang W. PMID: 42332688 [PubMed - as supplied by publisher]
	A stratified urine-based molecular diagnostic and prognostic model for non-muscle-invasive bladder cancer management. BMC Cancer Yi L, Ma Z, Zhang J, Zhan Y, Xiao H, Dai K, Liu Y, Gao Y, Yang X, Cao D, Xu D, Huang H. PMID: 42332658 [PubMed - as supplied by publisher]
	Prostate cancer and diabetes: A retrospective analysis of mortality trends in the United States (1999-2024). Medicine (Baltimore) Shahab SH, Mustafa FE, Masood HG, Ahmed S, Ali F, Sajid Y, Nazir A, Khalid M. PMID: 42332456 [PubMed - indexed for MEDLINE]
	Consistency of multiparametric MRI-guided transperineal prostate biopsy and Gleason score after radical prostatectomy: A retrospective observational study. Medicine (Baltimore) Wu Y, Xu L. PMID: 42332444 [PubMed - indexed for MEDLINE]
	The burden of cardiovascular disease in prostate cancer: prevalence, pathophysiology, and implications for integrated care. Support Care Cancer Ogieuhi IJ, Anthony CS, Ajekiigbe VO, Ayomikun AF, Iyawe EP, Adegbesan CA, Adeshina GA, Moradeyo A, Akingbola A, Ogunniyi KE. PMID: 42332138 [PubMed - indexed for MEDLINE]
	Comment on: cardiovascular and prostate cancer risk associated to testosterone replacement therapy-a systematic review and meta-analysis of 41 randomized controlled trials. Int J Impot Res Sansone A, Jannini EA. PMID: 42332077 [PubMed - as supplied by publisher]

Articles 1 - 20 / 179179

Page 1 of 8959



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy